Open Access
ARTICLE
Tet methylcytosine dioxygenase 2 suppresses renal cell cancer proliferation and metastasis by regulating the miR-200c-SCD axis
BENJIANG QIAN1, YOUFENG HUANG2, ZHENQIANG QIU2, XIAOYAN YING3, GUANG YANG3, HUIZHANG LI2,*, JIANMING TAN1,*
1 Fujian Provincial Key Laboratory of Transplant Biology, Department of Urology, Dongfang Hospital (900 Hospital of the Joint Logistics Team), School of Medicine, Xiamen University, Fuzhou, 350025, China
2 Institute of Ningde Urological Research and Department of Urology, Affiliated Mindong Hospital of Fujian Medical University, Fu’an, 355000, China 3 Department of Neurology, Affiliated Mindong Hospital of Fujian Medical University, Fu’an, 355000, China
* Address correspondence to: Jianming Tan, ; Huizhang Li,
BIOCELL 2021, 45(3), 599-615. https://doi.org/10.32604/biocell.2021.014633
Received 14 October 2020; Accepted 21 December 2020; Issue published 03 March 2021
Abstract
Tet methylcytosine dioxygenase 2 (TET2) acts as an antioncogene that is investigated in different cancers. But
the effects of TET2 in renal cell cancer (RCC) is still known little. Here, quantitative real-time PCR (qRT-PCR), Western
blot, and immunofluorescence were performed to exam gene and protein expression. Cell proliferation was measured
using Cell Counting Kit-8 (CCK-8). Transwell assay was performed to detect cell metastasis viability. Flow cytometry
was performed to analyze the cell cycle and cell apoptosis. The effects of TET2 on RCC growth in vivo was analyzed
using a mouse xenograft model.We found that TET2 and miR-200c were decreased in RCC tissues, and
hypermethylation of miR-200c promoter was found. Overexpression of TET2 promoted miR-200c expression by
reducing miR-200c promoter methylation. Additionally, overexpression of TET2 or miR-200c suppressed cell growth
and metastasis. Also, knockdown of miR-200c could moderate TET2 mediated cell growth inhibition. Furthermore,
we found miR-200c directly regulates Stearoyl-CoA desaturase (SCD) gene expression. Moreover,
in vivo experiment
results confirmed that TET2 inhibited tumor growth. In conclusion, TET2 acts as an antioncogene in RCC by
regulating the miR-200c-SCD axis and providing a potential target for RCC diagnosis and treatment.
Keywords
Cite This Article
QIAN, B., HUANG, Y., QIU, Z., YING, X., YANG, G. et al. (2021). Tet methylcytosine dioxygenase 2 suppresses renal cell cancer proliferation and metastasis by regulating the miR-200c-SCD axis.
BIOCELL, 45(3), 599–615. https://doi.org/10.32604/biocell.2021.014633